c

Dapagliflozin in chronic kidney disease (CKD)

30th May 2022 by Louise Hudman

Dapagliflozin in chronic kidney disease (CKD)

This is new guidance from NICE advising that dapagliflozin can be used for certain patients with CKD. This was released in March 2022.

When can dapagliflozin be used to treat chronic kidney disease (CKD)?

It can be used for treating CKD in adults. It can be used for the following patients.

  • Patients should be on optimised doses of ACE inhibitor (ACEi) or Angiotensin II receptor blockers (A2RBs) (unless contraindicated) before adding on dapagliflozin AND
    • Have an eGFR of 25 to 75 at the start of treatment AND
      • Have T2DM with any albumin-to-creatinine ratio (ACR) OR
        • Have ACR of 22.6 mg/mmol or more if they don’t have type 2 diabetes mellitus (T2DM).

Can GPs prescribe dapagliflozin for patients without diabetes?

Yes, patients without T2DM can, as long as their ACR is above 22.6.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

Related content

"I was introduced to the local locum chambers several months ago when I made a career move from partnership. I now combine salaried and locum roles. The chambers provides helpful support, leadership, advice and governance and reduces professional isolation. This combination of support reassures me and helps me provide safe and consistent care to patients within the community . There is a useful, innovative online portal - LocumDeck - which helps me access local work and which has efficient systems for reconciliation of finance including pensions. I would highly recommend joining a locum chambers for any GPs starting out in the locum world ."

Dr Adrian Richardson, GP

Dr Adrian Richardson, GP

See the full list of features within our NASGP membership plans

Membership